It Is Time for a Simplified Approach to Hepatitis B Elimination
Douglas T. Dieterich(Icahn School of Medicine at Mount Sinai), Mark Sulkowski(Johns Hopkins University), Camilla S. Graham(Harvard University), Kosh Agarwal(King's College - North Carolina), Chun‐Jen Liu(National Taiwan University), Young‐Suk Lim(Asan Medical Center), Su Wang(Rutgers, The State University of New Jersey), Paul Y. Kwo(Palo Alto University)
Cited by 26
Related Papers
Development of a simple noninvasive index to predict significant fibrosis in patients with HIV/HCV coinfection†‡
|Hepatology|2006|4.8k
Sofosbuvir for Hepatitis C Genotype 2 or 3 in Patients without Treatment Options
|New England Journal of Medicine|2013|1.1k
Influence of Human Immunodeficiency Virus Infection on the Course of Hepatitis C Virus Infection: A Meta‐Analysis
|Clinical Infectious Diseases|2001|969
ABT-450/r–Ombitasvir and Dasabuvir with Ribavirin for Hepatitis C with Cirrhosis
|New England Journal of Medicine|2014|877